XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3

STOCK AWARDS, WARRANTS AND OPTIONS (Tables)

9 Months Ended

Sep. 30, 2025

Summary of the activity of restricted stock awards

​

​	​	​	​	​	​
​	​	​	​	​	Weighted Average
​	​	Number of	​	​	Grant Date
​		RSAs	​		Fair Value
Outstanding at December 31, 2024		—	​	$	—
Granted		17,210	​		14.96
Vested		(17,210)	​		14.96
Expired/Cancelled		—	​		—
Outstanding at September 30, 2025		—	​	$	—

​

Warrant

Schedule of warrant activity

​

​	​	​	​	​	​
​	​	​	​	Weighted Average
​		Warrants		Exercise Price
Outstanding at December 31, 2024		4,935,621	​	$	5.70
Granted	​	—	​	​	—
Exercised	​	(699)	​	​	5.70
Outstanding at September 30, 2025		4,934,922	​	$	5.70

Schedule of outstanding warrants

​

​	​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	Warrants Outstanding			​	​	​	​	​
​	​	​	​	September 30,	​	December 31,	​	Exercise Price		​	Expiration
Type		Grant Date		2025		2024		per Share			Date
Common Warrants	​	10/3/2023	​	4,934,922	​	4,935,621	​	$	5.70	​	10/3/2030
​	​	​	​	4,934,922	​	4,935,621	​	​	​	​	​

Employee Stock Option

Schedule of fair value of option using Black-Scholes option

​

​	​	​	​	​	​
​		Nine months ended September 30,
​	​	2025	​	2024	​
Expected volatility		104 - 115	%	109 - 119	%
Expected term		5 - 6 years		5 - 7 years	​
Dividend yield		0	%	0	%
Risk-free interest rates		3.7 - 4.5	%	3.9 - 4.5	%

Schedule of employee and non-employee stock based compensation expense

​

​	​	​	​	​	​	​	​	​	​	​	​	​
​		Three months ended September 30,					​	Nine months ended September 30,
​		2025			2024			2025			2024
General and administrative	​	$	1,779,609	​	$	1,274,238	​	$	6,497,110	​	$	4,852,244
Research and development	​		2,217,739	​		777,045	​		6,886,790	​		2,617,244
Total	​	$	3,997,348	​	$	2,051,283	​	$	13,383,900	​	$	7,469,488

Schedule of employee and non-employee stock option

​

​	​	​	​	​	​	​	​	​
​	​	Number of	​	Weighted Average		​	Aggregate
​		Options		Exercise Price			Intrinsic Value
Outstanding at December 31, 2024		10,731,183	​	$	4.38		​	​
Granted		2,533,027	​		14.12		​
Exercised		(154,206)	​		3.20		$	1,359,331
Expired/Cancelled		(296,519)	​		10.18		​
Outstanding at September 30, 2025		12,813,485	​	$	6.18	​	$	33,377,698
Exercisable at September 30, 2025		8,223,709	​	$	4.32	​	$	27,762,799

X

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References

No definition available.

+ Details

Name:	capr_ScheduleOfEmployeeAndNonemployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTableTextBlock
Namespace Prefix:	capr_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all warrant activity during the period.

+ References

No definition available.

+ Details

Name:	capr_ScheduleOfWarrantActivityTableTextBlock
Namespace Prefix:	capr_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: